1998 - 2008
2009
2013
2019
2021
2025+ beyond
A decade building partnerships and investment in oncology drug development and clinical technologies.
Branded as Novella Clinical, reinforcing our commitment to move potential forward for emerging biopharmas with a specialty focus on oncology.
Acquired by Quintiles (now IQVIA) to expand insights and expertise in serving emerging biopharma and biotech companies.
Novella gained strength and expertise serving the biotech market and relaunched the brand in 2019 as IQVIA Biotech.
IQVIA Biotech expands into Japan and Asia
Pacific (JAPAC) providing a custom-built delivery solution for biotech
customers.
More than 25 years supporting biotechs from innovation to patient impact. We are committed to improving lives for a healthier world.
Our story
Our history in clinical development is built on more than 25 years of unmatched experience supporting biotech sponsors with therapeutic and scientific expertise.